Adalimumab-Aqvh

YUSIMRY

Tumor Necrosis Factor Blocker

NADAC/unit $604.1525

No Shortage

Adalimumab-Aqvh suppresses inflammation by blocking tumor necrosis factor, used in autoimmune conditions.

vs. brand YUSIMRY: Generic saves up to -5942% per unit

Covered Lives

Explore in the Ecosystem

rxsaver.aiCompare prices for Adalimumab-Aqvh drfinder.aiFind doctors who prescribe Adalimumab-Aqvh rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Adalimumab-Aqvh

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.